PBPetra Došenović Bonča

Petra Došenović Bonča

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Petra Došenović Bonča has a total of 86 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Comparative Analysis of the Economic Burden of Breast, Colorectal and Lung Cancer-Related Premature Mortality in Slovenia: Value-Added Decomposition by Occupation-Gender Groups

    by Tjaša Redek, Tanja Istenič, Petra Došenović Bonča, Ivica Ratoša, Andraž Perhavec, Daša Farčnik

    Introduction: This paper aims to estimate the value-added loss attributable to premature deaths from breast, colorectal and lung cancer in Slovenia using a novel methodology using linked employer-employee data, enabling value-added decomposition by occupation-gender groups. Methods: The analysis is based on population-level microdata for the 2016–2022 period matched from several sources. Premature mortality costs are estimated using occupation- and gender-specific output losses rather than assuming uniform productivity across working-age individuals. We approximate intangible capital using each firm's occupational and gender structure and estimate productivity losses due to premature mortality by specific occupation, revealing differences in the economic footprint of different cancer types. Results: On average, the loss of value added from a premature death due to colorectal cancer is between €352,000 and €392,000, from lung cancer, on average, between €150,000 and €178,000 and from breast cancer, around €436,000. In total, given that Slovenia's GDP in 2024 was around €66 billion (€52 billion at constant 2015 prices), the total value-added loss associated with these three cancer types amounted to about 0.5% of Slovenia's 2024 GDP. Over the study period, premature mortality attributable to these cancers translated into an estimated cumulative (current and future) GDP loss of roughly €371 million. Conclusions: Results indicate that notable reductions in indirect costs could be achieved in Slovenia through efficient and effective measures to manage the burden of cancer, including cancer screening programmes, other primary prevention approaches, timely access to diagnostics and treatment, and return-to-work policies.

  • Open Access

    Inpatient Burden, Costs, and Characteristics of Peripheral Artery Disease in Slovenia

    by Tjaša Furlan, Borut Jug, Jerneja Farkaš-Lainščak, Dalibor Gavrić, Irena Ograjenšek, Petra Došenović Bonča

    Introduction: We assessed inpatient burden, costs, demographics, comorbidity patterns, and outcomes of peripheral artery disease (PAD) in Slovenia. Methods: We included patients hospitalised for PAD (primary diagnosis, International Classification of Diseases, 10th revision, code I70.2–I70.9) in Slovenia between January 1st, 2015, and December 31st, 2022. We estimated crude and age-standardised hospitalisation rates, hospitalisation reimbursement costs, patient characteristics (age and sex distribution, disease severity and prevalence of comorbidities), uptake of revascularisation, major amputations and in-hospital mortality. Results: We included 15,978 patients (60% men, median age 72 years, 32% chronic limb-threatening ischaemia) with 27,139 hospital episodes, yielding a mean of ~3,400 hospitalisations per year (hospitalisation rate 161 per 100,000/year). Median direct cost (inflation-adjusted to 2025) per hospital episode was €3,177, yielding total costs of €10.8 million/year. The most common comorbidities were arterial hypertension (35%), dyslipidemia (21%) and diabetes mellitus (19%), with a significantly higher prevalence in patients with chronic limb-threatening ischaemia. During the observation period, revascularisation procedures increased from 77.5% to 80.2%, while major amputations decreased from 13.2% to 7.9%, and mortality decreased from 5.0% to 3.3%. Conclusions: The inpatient burden of PAD is considerable in Slovenia. Patients hospitalised for PAD have a high burden of comorbidities, especially when presenting with chronic limb-threatening ischaemia; nonetheless, in-hospital major amputations and mortality decreased substantially over the last decade.

  • Open Access

    The Societal and Patient-Level Burden of Sickness Absenteeism in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Across Two Decades in Slovenia

    by Mitja Oblak, Aleša Lotrič Dolinar, Žiga Rotar, Matija Tomšič, Petra Došenović Bonča

    Introduction: To analyse the long-term dynamics of the burden of sickness absenteeism (SA) at the societal and patient levels in employed patients with selected inflammatory rheumatic diseases (IRDs). Methods: The burden of SA was analysed over 2 decades prior to the COVID-19 pandemic, with a focus on the subperiod following the introduction of the rheumatology clinical registry biorx.si. Population data for full-time employees on sick leave due to rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS) were obtained from the national administrative database. The societal burden of SA was defined as the total annual number of calendar days on sick leave. The patient-level burden of SA was defined as the average annual number of days on sick leave per patient which was further disaggregated into the average annual number of sick leave episodes per patient and the average annual number of days per sick leave episode. The costs of SA were estimated using the human capital approach. An exponential trend method was used for analysis, and time series were tested for structural breaks. Results: The societal burden of SA during the subperiod following the registry introduction decreased, on average, by 3.3% annually among RA patients. The average annual increase in the societal burden of SA was marginal for PsA patients (0.4%) and substantial for AS patients (8.7%). The societal and patient-level burdens of SA varied by sex and job sector. The patient-level burden of SA, however, decreased on average by 2.5% annually for RA patients and increased marginally for both PsA and AS patients. The key pattern suggesting potential improvements in the patient-level burden of SA for the analysed IRDs was an increase in the number of sick leave episodes per patient, offset by shorter episode duration. Conclusions: A study of the societal burden of SA, including its components, and the patient-level burden of SA can support the development of more effective strategies for managing SA and facilitating a faster return to work.


  • Open Access

    Evidence on Social and Economic Dimensions of Informal Caregiving in Slovenia

    by Nina Ponikvar, Sara Ražman, Tjaša Redek, Petra Došenović Bonča

    Purpose: This paper examines key socio-demographic and health characteristics of informal caregivers and selected lifestyle pattern indicators in Slovenia. It also provides estimates of the economic value of unpaid caregiving.Design/methodology/approach: Using nationally representative data (n =1,075) collected in 2025 through a comprehensive questionnaire, we provide evidence on caregiver profiles through logistic regression modelling.Findings: The results indicate that older age and engagement in flexible or self-directed forms of employment significantly increase the likelihood of providing informal care, while notable differences emerge in the prevalence of specific health conditions, mental well-being indicators, and lifestyle patterns between caregivers and non-caregivers. Self-reported general health status does not differ significantly across the two groups, yet caregivers exhibit higher rates of musculoskeletal disorders, injuries, and certain chronic conditions. By combining data from the questionnaire with estimates from other large-scale studies on caregivers’ and their caregiving time, we estimate the economic value of unpaid caregiving at €2.1–€4.1 billion, representing approximately 3–6% of Slovenia’s GDP.Academic contribution to the field: This study contributes to the academic literature by providing the important nationally representative evidence on the socio-demographic, health, and lifestyle characteristics of informal caregivers in Slovenia. It advances research on the economics of care by combining caregiver profiling with macroeconomic valuation, thereby linking micro-level health and employment data with macro-level cost estimates of unpaid caregiving.Research implications: The findings underscore the substantial but largely unrecognised contribution of informal caregivers to the national long-term care system and emphasise the importance of considering the burden of informal care in designing not only social and health policies but also labour market measures addressing the well-being and workability of caregivers, thereby enabling sustainable complementarity between informal care and formal care systems. The evidence highlights the need to integrate support for informal caregivers into social, health, and labour market policies to sustain their ability to work and ensure the complementarity of informal and formal care. Future research could build on these findings by adopting longitudinal approaches to assess causal effects of caregiving on health and labour market outcomes.Originality/significance/value: This study combines nationally representative survey data on caregiver characteristics in Slovenia with macroeconomic valuation of unpaid caregiving, providing novel evidence for policy and research.

  • Open Access

    Economic burden of blindness and moderate to severe vision impairment in Slovenia

    by Nina Vidic Krhlikar, Dalibor Gavrić, Mojca Globočnik Petrovič, Karmen Janša, Nataša Vidović Valentinčič, Petra Došenović Bonča

    Blindness and moderate to severe vision impairment (MSVI) represent a substantial health and economic burden. This study aimed to provide the first populat

  • Open Access

    Transferability of Real World Evidence to Support HTA Recommendations in Lower Income European Countries

    by Zoltán Kaló, Guenka Petrova, Bertalan Németh, Petra Došenović Bonča, Diana Delnoij, Alastair Bennett, Konstantin Tachkov, Yingying Zhang, Noemi Kreif, Saskia Knies, et al.

    Background and Aims: Lower income European countries (LIECs) have more limited financial resources to cover high‐cost technologies in rare diseases than higher income European countries (HIECs). Our study explores how treatment recommendations in myelodysplastic syndrome (MDS) can be supported in LIECS by transferring real‐world evidence (RWE) generated by target trial emulation (TTE) method in HIECs. Method: In the HTx project transferability aspects of the MDS case study were considered upfront. HTA agency consortium partners set expectations for the MDS case study team on how to integrate the new TTE methodology into the routine work of HTA bodies. In consecutive workshops consortium members and external HTA experts identified the main challenges of transferring evidence generated by TTE method to LIECs and made conclusions on how to overcome these challenges. Results: The lack of local real‐world data before making reimbursement decisions is an important challenge to apply the TTE method to LIECs. Differences in patient pathways and comparator technologies, limited expertise and resources for adapting international HTA methods are significant barriers of transferring RWE from other countries. Still, transferring RWE to LIECs from other countries based on the TTE methodology represents an improvement to the current standard HTA methods, especially if joint clinical assessment provides the unbiased judgement on the relative effectiveness of orphan medicines. The TTE approach also provides an opportunity to LIECs to judge the value of high‐cost technologies for different patient subgroups. However, HTA professionals in LIECs need training about advanced methodologies. Conclusion: This is the first study to explore how RWE generated by the TTE method can be transferred to optimize treatment decisions of patients with a rare disease in countries with limited HTA capacities. Five general concluding statements were made on the novelty of the TTE method and on how to overcome main challenges of transferring TTE results to HTA systems in LIECs.


  • Open Access

    Economic Evaluations of Digital Health Interventions: A Bibliometric Analysis and a Review of Methodological Challenges

    by Antonija Srok, Petra Došenović Bonča

    Background: Digital health interventions (DHI) have been identified as a tool that has the potential to meet the growing demand for healthcare, improve the efficiency and sustainability of healthcare, and increase the accessibility and quality of care. The adoption and use of DHI for healthcare was strongly encouraged during the COVID-19 pandemic, resulting in a sharp increase in the number of DHI-related publications. Objectives: The number of DHI’s economic evaluations (EE) is significantly smaller, accounting for less than 5% of publications on DHI. However, they are essential for demonstrating DHI’s cost-effectiveness relative to comparable healthcare interventions. Methods/Approach: We conduct a bibliometric analysis of publications on EE of DHI extracted from the Web of Science Core Collection. Results: We analyse 2,308 publications from 2005 to 2023 and present the most influential countries, organisations, journals, and publications along with the corresponding bibliometric networks to explore the existing literature on EE of DHI. Furthermore, we systematise concerns and methodological challenges surrounding the economic justification of DHI. Conclusions: This paper aims to build a knowledge base for future research to improve EE of DHI, given that only strong clinical and economic evidence can adequately inform resource allocation decisions and thereby encourage adoption of DHI.


  • Open Access

    Assessment of financial toxicity in patients with cancer in Slovenia

    by Katja Vöröš, Marjeta Skubic, Mojca Bavdaž, Petra Došenović Bonča, Andraž Perhavec, Tjaša Redek, Helena Barbara Zobec Logar, Ivica Ratoša

    Purpose: The aim of this study was to assess the extent of financial toxicity in patients with cancer in Slovenia, measured as perceived financial strain and out-of-pocket expenditures. Methods: The prospective, cross-sectional study was done at Institute of Oncology Ljubljana from June to October 2023. A newly created individual questionnaire was utilized to obtain data on financial toxicity. Patients completed the questionnaire either on paper or online, with or without the assistance of a researcher. The statistical analysis was based on descriptive and inferential statistics. Results: A total of 901 surveys were disseminated, of which 659 were returned, corresponding to a response rate of 73%. Most patients had compulsory health insurance and were diagnosed in the public healthcare system. Following a cancer diagnosis, 178 (27%) patients reported a decline in financial satisfaction (subjective assessment), while 150 (22.7%) patients observed a change in their financial capability (objective assessment). Younger patients (p < 0.001), female patients (p < 0.004), patients with lower net household income (p < 0.001), and patients who were employed before the diagnosis (p < 0.001) were at a greater risk for financial toxicity. Patients with breast cancer and colorectal, endometrial, skin (including melanoma), esophageal, stomach, kidney, bladder cancers, and lymphoma had higher self-reported subjective and objective financial toxicity than patients with prostate, lung, and head and neck cancer. Conclusion: This article represents the first comprehensive assessment of financial toxicity among patients with cancer in Slovenia, using perceived financial strain and out-of-pocket expenditures. Most patients reported no significant out-of-pocket costs for the treatment they received. About a quarter of patients with cancer experience financial difficulties.


  • Open Access

    Financial Toxicity Among Cancer Patients in Slovenia

    by Marjeta Skubic, Katja Vöröš, Mojca Bavdaž, Petra Došenović Bonča, Andraž Perhavec, Tjaša Redek, Ivica Ratoša, Helena Barbara Zobec Logar

    Background: The ageing population, increasing medical costs and a number of newly diagnosed cancer cases among the working population are increasing the financial burden on healthcare systems. The extent of financial toxicity in Slovenian patients has been insufficiently researched, as has its impact on quality of life (QoL).Methods: To evaluate financial toxicity, the Functional Assessment of Chronic Illness Therapy (COST‐FACIT) questionnaire was translated into Slovenian, validated, introduced and compared with the European Organisation for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ‐C30). Additional questions were incorporated into the questionnaire to further quantify and objectify financial toxicity.The study was cross‐sectional. The statistical analysis was based on descriptive and inferential statistics and exploratory data analysis.Results: Out of 590 analysed participants, financial toxicity was absent in 57.2% but present at mild to moderate levels in 42.8%. Key risk factors included lower income, age ≤ 65, employment, active oncologic treatment, rural residence and religious affiliation. Post hoc analyses showed higher financial toxicity in those with ≤ 600 EUR monthly income, employed patients and spiritual individuals, while cancer type showed no significant differences. The correlation between financial toxicity and QoL was mild. Objective measures of financial toxicity include direct costs (e.g., transportation, supplements and medical devices) and indirect costs (e.g., loss of income) associated with disease and treatment, which burdened more than 40% of the studied population.Conclusions: The COST‐FACIT proved to be a helpful screening tool for identifying patients at risk, even in a public healthcare system such as the Slovenian system. On average, financial toxicity is low due to the publicly funded financial system covering the treatment and rehabilitation of malignant diseases. The age structure of cancer patients and secure pension income further contribute to this outcome.


  • Open Access

    Uptake and Effectiveness of Outpatient vs. Residential Cardiac Rehabilitation After Myocardial Infarction: A Nationwide Analysis

    by Borut Jug, Zlatko Fras, Tjaša Furlan, Marko Novaković, Jerneja Tasič, Mitja Lainščak, Jerneja Farkaš, Dalibor Gavrić, Irena Ograjenšek, Petra Došenović Bonča

    Aims: To estimate the participation in, and the comparative effectiveness of, short-term residential and comprehensive outpatient cardiac rehabilitation (CR), after the latter was introduced in Slovenia by establishing dedicated regional CR centers. Methods: We extracted and analyzed data on all patients hospitalized for myocardial infarction in Slovenia (n = 15,639), focusing on CR participation – either comprehensive outpatient (introduced in 2017) or short-term residential (available throughout the study period 2015–2021). Impact on nation-wide CR participation rates was assessed by interrupted time series analysis; impact on patient-level outcomes (all-cause mortality and cardiovascular hospitalizations) was assessed using Kaplan Meier estimators and ‘doubly robust’ Cox regression with propensity score-derived inverse probability of treatment weighting. Results: Of the 11,815 eligible patients (event-free after 180-day landmark), 3819 (32.3%) attended CR. Nation-wide CR participation rates increased both in level (9.7%, 95% CI 6.3–3.1) and in trend (0.41% per month, 95% CI 0.22–0.60) after outpatient CR was introduced in 2017. After propensity score-based adjustment, participation in either CR was associated with lower event rates (12.8%, 17.2%, and 21.0% at 3-year follow-up for outpatient, residential, and no CR, respectively; p < 0.001). Risk reductions were significant for composite outcomes (outpatient: HR 0.58, 95% CI 0.47–0.70; residential: HR 0.79, 95% CI 0.68–0.93) and all-cause mortality (outpatient: HR 0.56, 95% CI 0.38–0.83; residential: HR 0.59, 95% CI 0.45–0.77), whereas the risk reduction for cardiovascular hospitalizations was only significant for outpatient CR (HR 0.60, 95% CI 0.48–0.74). The incremental cost-effectiveness ratio per life-year gained was €6421 and €7381 for outpatient and residential CR, respectively. Conclusions: Participation in either CR improves outcomes after myocardial infarction, but comprehensive outpatient CR conveys superior risk reductions, primarily through reduced cardiovascular hospitalizations. Lay Summary Our study highlights the importance of expanding cardiac rehabilitation services (by setting up dedicated regional comprehensive outpatient centers) and provides new evidence on improved outcomes in patients after myocardial infarction, who undergo cardiac rehabilitation. While previous studies have demonstrated the efficacy and effectiveness of cardiac rehabilitation, ours is the first to compare two distinctive cardiac rehabilitation modalities – comprehensive outpatient (introduced in 2017) and short-term residential (available throughout the study period 2015–2021). In our nationally representative population of patients after myocardial infarction (n = 15,639), participation in cardiac rehabilitation increased both in level (by ~10%) and in trend (by ~0.4% per month) after dedicated cardiac rehabilitation centers were established. Participation in either comprehensive outpatient or short-term residential cardiac rehabilitation was associated with a significant 42% and 21% risk reduction in the primary outcome (death or cardiovascular hospitalization) respectively, after propensity score-based adjustment. Mortality was also reduced (by 46% and 41%, respectively), whereas the risk reduction for hospitalization was only significant in patients undergoing comprehensive cardiac rehabilitation (by 60%). Participation in either cardiac rehabilitation program improves cardiovascular outcomes, but comprehensive outpatient cardiac rehabilitation yields superior risk reductions, primarily through reduced cardiovascular hospitalizations. Key Learning Points What is already known? Cardiac rehabilitation improves outcomes in patients with coronary artery disease. Despite its established efficacy, cardiac rehabilitation participation remains suboptimal. Improving access to cardiac rehabilitation through establishing dedicated regional centers may improve participation, but also crowd-out existing options of cardiac rehabilitation. The comparative effectiveness of different cardiac rehabilitation modalities (e.g., comprehensive outpatient versus short-term residential cardiac rehabilitation) remains understudied. What does this study add? Expanding cardiac rehabilitation services (by setting up dedicated regional comprehensive outpatient centers) significantly improves participation in cardiac rehabilitation after myocardial infarction. Participation in either comprehensive outpatient or short-term residential cardiac rehabilitation after myocardial infarction is associated with improved outcomes (i.e., a significant 42% and 21% risk reduction in death or cardiovascular hospitalization, respectively). Comprehensive outpatient cardiac rehabilitation yields superior risk reductions primarily through reduced cardiovascular hospitalizations.